Author

Min Yao

Senior Research Scientist, Tri-Institutional Therapeutics Discovery Institute - Cited by 491 - Antibody - Cancer - Immunotherapy

Biography

Dr. Min Yao is working in Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Provincial Key Laboratory for Transfusion-transmitted Infectious. His areas of interest in research includes in the treatment and pathology of infectious disease, Blood transfuson, cancer, immunotherapy. Most of his contributions and publications were related to the field of blood transfusions, infectious diseases, immunotherapy. 
Title
Cited by
Year
Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment
WB Fang, M Yao, G Brummer, D Acevedo, N Alhakamy, C Berkland, ...Oncotarget 7 (31), 49349, 2016201
104
2016
Cytokine regulation of metastasis and tumorigenicity
M Yao, G Brummer, D Acevedo, N ChengAdvances in cancer research 132, 265-367, 2016201
92
2016
CCR2 chemokine receptors enhance growth and cell-cycle progression of breast cancer cells through SRC and PKC activation
M Yao, W Fang, C Smart, Q Hu, S Huang, N Alvarez, P Fields, N ChengMolecular Cancer Research 17 (2), 604-617, 2019201
49
2019
Chemokine signaling facilitates early-stage breast cancer survival and invasion through fibroblast-dependent mechanisms
G Brummer, DS Acevedo, Q Hu, M Portsche, WB Fang, M Yao, B Zinda, ...Molecular Cancer Research 16 (2), 296-308, 2018201
43
2018
Priming cancer cells for drug resistance: role of the fibroblast niche
WB Fang, M Yao, N ChengFrontiers in biology 9, 114-126, 2014201
38
2014
The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells
WB Fang, M Yao, I Jokar, N Alhakamy, C Berkland, J Chen, ...Breast cancer research and treatment 150, 309-320, 2015201
37
2015
Elevated expression of chemokine CC ligand 2 in stroma is associated with recurrent basal-like breast cancers
M Yao, E Yu, V Staggs, F Fan, N ChengModern Pathology 29 (8), 810-823, 2016201
32
2016
TGF-β negatively regulates CXCL1 chemokine expression in mammary fibroblasts through enhancement of Smad2/3 and suppression of HGF/c-Met signaling mechanisms
WB Fang, B Mafuvadze, M Yao, A Zou, M Portsche, N ChengPloS one 10 (8), e0135063, 2015201
30
2015
Carcinomas assemble a filamentous CXCL12–keratin-19 coating that suppresses T cell–mediated immune attack
Z Wang, P Moresco, R Yan, J Li, Y Gao, D Biasci, M Yao, J Pearson, ...Proceedings of the National Academy of Sciences 119 (4), e2119463119, 202
22
2022
Continuous delivery of neutralizing antibodies elevate CCL2 levels in mice bearing MCF10CA1d breast tumor xenografts
M Yao, C Smart, Q Hu, N ChengTranslational Oncology 10 (5), 734-743, 171
20
2017
Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion
Q Hu, M Myers, W Fang, M Yao, G Brummer, J Hawj, C Smart, C Berkland, ...Biology open 8 (7), bio040873, 202
19
2019
Pancreatic cancer cells assemble a CXCL12-keratin 19 coating to resist immunotherapy
Z Wang, R Yan, J Li, Y Gao, P Moresco, M Yao, JF Hechtman, MJ Weiss, ...BioRxiv, 776419, 2019201
5
2019

Referred From: https://scholar.google.com/citations?user=olm7t5kAAAAJ&hl=en

Cited by
Citations 491
h-index 11
i10-index 11
Recommended Journals
Open Access Journals